根据一项新研究，礼来公司（Eli Lilly）研发的一种下一代减肥药物与Zepbound联合使用时，能够帮助患者比单独使用Zepbound时减轻更多的体重。
A next-generation weight-loss drug from Eli Lilly LLY 0.28%increase; up pointing triangle, when combined with Zepbound, helped people lose substantially more weight than Zepbound alone, according to a new study.
这种名为eloralintide的实验性注射剂模仿了一种名为胰高血糖素样肽-1（amylin）的激素的作用，这种激素在进食后能传递饱腹感。该研究在2型糖尿病患者中进行了测试。
The experimental injection, eloralintide, which mimics a hormone called amylin that helps signal fullness after eating, was studied in combination with a Zepbound shot in patients with Type 2 diabetes.